Product
Eureka
For R&D, Eureka makes reading and utilizing patents & technical documents easy.
Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
62 results about "Mycoplasma synoviae" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A species of gram-negative bacteria pathogenic to CHICKENS; TURKEYS, and guinea fowls. It causes disease in a wide variety of organs and tissues including JOINTS, tendon sheaths and the RESPIRATORY TRACT.
Preparation method of mycoplasma gallisepticum and mycoplasma synoviae bivalent inactivated vaccine
ActiveCN103479995AImproving immunogenicityAvoid infectionAntibacterial agentsBacterial antigen ingredientsImmune effectsMycoplasma synoviae
The invention relates to a preparation method of a mycoplasma gallisepticum and mycoplasma synoviae bivalent inactivated vaccine. The method comprises the steps as follows: a mycoplasma gallisepticum virulent CR strain and a mycoplasma synoviae HN01 strain which have good immunogenicity are inoculated on a proper culture medium for cultivation, so that a culture is acquired; and the culture is inactivated through a formaldehyde solution and then is mixed with an oil emulsion adjuvant and emulsified, so that the mycoplasma gallisepticum and mycoplasma synoviae bivalent inactivated vaccine is prepared. The mycoplasma gallisepticum and mycoplasma synoviae bivalent inactivated vaccine is used for preventing mycoplasma gallisepticum and mycoplasma synoviae diseases, and can realize immunization, prevent two pathogens at the same time and reduce the workload of immunization; and the prepared vaccine is stable in performance, good in immune effect, and more suitable for actual production of China.
Owner:兆丰华生物科技(南京)有限公司
Preparation method of inactivated mycoplasma synoviae vaccine
ActiveCN103495160AIncrease productionReduce manufacturing costAntibacterial agentsBacterial antigen ingredientsMycoplasma synoviaeAdjuvant
The invention relates to a preparation method of an inactivated mycoplasma synoviae vaccine. The vaccine provided by the invention is prepared by the following steps of inoculating a mycoplasma synoviae HN01 strain with good immunogenicity to a proper culture medium, harvesting cultures, inactivating the cultures by utilizing a formaldehyde solution, and adding an adjuvant to carry out mixing and emulsification. The vaccine is used for preventing the mycoplasma synovial and has the advantages of good security, high immune efficacy and the like.
Owner:兆丰华生物科技(南京)有限公司
Bi-fluorescence quantitative RT-PCR detection kit for mycoplasma synoviae and avian reovirus, and primer group thereof
ActiveCN104263858ARealize the purpose of one tube and two inspectionsSensitivity not affectedMicrobiological testing/measurementMicroorganism based processesMycoplasma synoviaeFluorescence
The invention discloses a bi-fluorescence quantitative RT-PCR detection kit for mycoplasma synoviae and avian reovirus. The kit comprises a primer group and a probe group, wherein the primer group comprises a primer 1, a primer 2, a primer 3 and a primer 4, which respectively have base sequences of sequence tables SEQ.ID.No.1 and 2, and SEQ.ID.No.4 and 5; and the probe group comprises a probe A and a probe B which respectively have the base sequences of sequence tables SEQ.ID.No.3 and 6. Experiments prove that the kit disclosed by the invention has the advantages of short detection time, high detection sensibility and strong specificity, two pathogens of the mycoplasma synoviae and the avian reovirus can be detected and discriminated at the same time, and the corresponding pathogeny content can be quantified, so that the kit can be used for assessing the curative effects of vaccines and medicines on the mycoplasma synoviae and the avian reovirus and researching pathogenic mechanisms and other respects; therefore, the kit disclosed by the invention has an important significance on prevention and control of the mycoplasma synoviae and the avian reovirus.
Owner:GUANGXI VETERINARY RES INST
Preparation method of attenuated vaccine of mycoplasma synoviae
InactiveCN110151984ALong durationWith cross protectionAntibacterial agentsBacterial antigen ingredientsMycoplasma synoviaeImmune effects
An H95 attenuated mycoplasma synoviae strain is obtained through in-vitro subculture in order to research an attenuated vaccine capable of preventing mycoplasma synoviae. The H95 strain and a white oil adjuvant are mixed in the proportion of 1:1 to prepare the attenuated vaccine, and the immune effect of the strain on chickens is researched by immunizing the chickens with different immune doses; animal infection research is carried out through a pathogenicity wild strain, so that the prevention effect of the attenuated vaccine prepared from the H95 attenuated strain on mycoplasma synoviae is verified. The invention provides a preparation method of the attenuated vaccine capable of preventing mycoplasma synoviae and an effective immunizing dose. A scientific basis is provided for clinicallypreventing mycoplasma synoviae.
Owner:NINGXIA UNIVERSITY +1
Multi-fluorescent immunoassay method for rapidly distinguishing 6 types of poultry respiratory pathogens
ActiveCN106191319AAvoid crossbreedingGuaranteed temperatureMicrobiological testing/measurementDNA/RNA fragmentationBiotin-streptavidin complexMycoplasma synoviae
The invention discloses a multi-fluorescent immunoassay method for rapidly distinguishing 6 types of poultry respiratory pathogens. The multi-fluorescent immunoassay method is simple to operate; a target amplified fragment is obtained through a PCR (Polymerase Chain Reaction); then an amplified product, fluorescence coded microspheres and streptavidin-phycoerythrin are hybridized; an MFI (Mean Fluorescence Intensity) value is read through a detector to distinguish viruses of different types. According to the method disclosed by the invention, avian influenza viruses, chicken infectious bronchitis viruses, chicken Newcastle disease viruses, chicken infectious laryngotracheitis viruses, mycoplasma gallisepticum and mycoplasma synoviae can be accurately detected at the same time; the multi-fluorescent immunoassay method has high specificity, high sensitivity and good repeatability. Compared with a traditional detection method, the method disclosed by the invention realizes simultaneous detection of a plurality of types of different target molecules in the same sample; the use amount of the sample is less; the method is simple and rapid to operate and the detection cost can be greatly reduced.
Owner:GUANGDONG LAB ANIMALS MONITORING INST
Multiple fluorescence immunoassay method for detecting mycoplasma gallisepticum and mycoplasma synoviae
InactiveCN106222256AAvoid crossbreedingGuaranteed temperatureMicrobiological testing/measurementDNA/RNA fragmentationBiotin-streptavidin complexMycoplasma synoviae
The invention discloses a multiple fluorescence immunoassay method for detecting mycoplasma gallisepticum and mycoplasma synoviae. The multiple fluorescence immunoassay method has the advantages that the operation is simple; a target amplified fragment is obtained through PCR (polymerase chain reaction), then the amplified fragment, fluorescent encoding microspheres, and streptavidin-phycoerythrin are hybridized, and an MFI (mean fluorescence intensity) value is read through a detection instrument, so as to distinguish different types of pathogens; the mycoplasma gallisepticum and mycoplasma synoviae can be simultaneously detected and identified; the specificity is strong, the sensitivity is high, the repeatability is good, and the like; multiple types of molecules with different purposes in the same sample can be simultaneously detected; the flexibility is good, and the type of to-be-detected pathogens can be increased or decreased on the basis according to requirements.
Owner:GUANGDONG LAB ANIMALS MONITORING INST
Product, method and application for simultaneously detecting mycoplasma gallisepticum and mycoplasma synoviae
ActiveCN112048566AStrong specificityHigh sensitivityMicrobiological testing/measurementBiological material analysisMycoplasma synoviaeAntigen
The invention discloses a product, method and application for simultaneously detecting mycoplasma gallisepticum and mycoplasma synoviae. According to the product and the method, a common specific protein antigen of mycoplasma gallisepticum and mycoplasma synoviae is preferably an outer membrane protein WP-041352022.1 as a detection object, a PCR primer pair S1 is designed and screened on the genome DNA level of the protein, and the PCR primer pair has the advantages of strong specificity, high sensitivity and no primer dimer generation. The invention provides a product and a method for simultaneously detecting two pathogens by using one pair of PCR primers, mutual interference between multiple PCR primers and the product is avoided, the detection rate is improved, and the method has the advantages of economy, simplicity, convenience and high efficiency.
Owner:SHANDONG LVDU BIO SICIENCE & TECH
Multiple fluoroimmunoassay method capable of quickly differentiating infectious laryngotracheitis virus (ILTV), infectious bronchitis virus (IBV), myeoplasma gallisepticum (MG) and mycoplasma synoviae (MS) and reagent
ActiveCN106011313AReduce dosageAvoid crossbreedingMicrobiological testing/measurementDNA/RNA fragmentationMycoplasma synoviaeFluorescence
The invention discloses a multiple fluoroimmunoassay method capable of quickly differentiating infectious laryngotracheitis virus (ILTV), infectious bronchitis virus (IBV), myeoplasma gallisepticum (MG) and mycoplasma synoviae (MS) and a reagent. The method is simple to operate, a target amplified fragment is obtained through polymerase chain reaction (PCR); an amplified product, fluorescence coded microspheres and streptavidin-phycoerythrin are hybridized, a mean fluorescence intensity (MFI) value is read through a detector, and pathogens of different types are differentiated. According to the method, avian infectious laryngotracheitis virus, infectious bronchitis virus, myeoplasma gallisepticum and mycoplasma synoviae can be accurately detected simultaneously, and the method is high in specificity and sensitivity and good in repeatability. Compared with a conventional detection method, the method can be used to simultaneously detect various target molecules in an identical sample, the sample usage amount is small, the method is simple and quick to operate, and the detection cost can be greatly reduced. The method is good in flexibility, and the varieties of detected pathogens can be increased or decreased as required on the basis.
Owner:GUANGDONG LAB ANIMALS MONITORING INST
Mycoplasma synoviae culture method
InactiveCN105838641AReduce incubation timeReduce mistakesBacteriaMicroorganism based processesMycoplasma synoviaeHorse serum
The invention provides a mycoplasma synoviae culture method including three steps of first-level seed breeding, seed solution preparation and bacterial liquid preparation. A used liquid culture medium comprises the components: PPLO broth with the concentration of 21.0 g / L, glucose with the concentration of 5.0 g / L, inactivated horse serum with the concentration of 200 ml / L, a 25% yeast extract liquid with the concentration of 200 ml / L, a 1% phenol red solution with the concentration of 1.0 ml / L, a 1% coenzyme I solution with the concentration of 30 ml / L, and a 1% L-cysteine solution with the concentration of 30 ml / L, wherein the pH value is adjusted to 7.6-7.8. The process method not only shortens the culture time of mycoplasma synoviae, but also reduces the procedures of multiple sampling and detection during culture, reduces the possibility of pollution in the culture process, reduces errors caused by manual operation, and has advancement compared with the prior art.
Owner:YEBIO BIOENG OF QINGDAO
Pharmaceutical composition for treating chicken mycoplasma synoviae and application thereof
InactiveCN108853217AReduce usageSimple processAntibacterial agentsAntipyreticDiseaseMycoplasma synoviae
The invention relates to a pharmaceutical composition for treating chicken mycoplasma synoviae diseases. The pharmaceutical composition is prepared from the following raw materials in parts by mass: 20 to 40 parts of cortex eucommiae, 10 to 30 parts of radix gentianae macrophyllae, 10 to 20 parts of radix stephaniae tetrandrae, 10 to 20 parts of caulis spatholobi, 10 to 20 parts of cassia twig, 10to 20 parts of rhizoma polygoni cuspidati, 20 to 60 parts of radix astragali seu hedysari and 10 to 20 parts of liquorice root; the raw materials can be prepared into two preparations including granules and an oral solution. The traditional Chinese medicine composition provided by the invention has the effects of expelling wind and dispersing cold and eliminating dampness, promoting blood circulation, removing blood stasis and dredging collaterals, nourishing liver and kidney and strengthening body resistance to eliminate pathogenic factors, so that the effect of treating the chicken mycoplasma synoviae diseases is realized. Safety evaluation and clinical case application of the traditional Chinese medicine composition prove that the pharmaceutical composition has a remarkable effect of treating the chicken mycoplasma synoviae diseases, is a pure traditional Chinese medicine preparation, has high safety and a simple technology and is easy to popularize.
Owner:SHENYANG VICA ANIMAL HUSBANDRY TECH +1
Novel genetic engineering subunit vaccine for chicken mycoplasma synoviae
InactiveCN110025778AOutstanding advantagesOutstanding effectAntibacterial agentsBacterial antigen ingredientsMycoplasma synoviaeVaccine Production
The application of the invention provides an immune composition and a subunit vaccine. The immune composition contains chicken mycoplasma synoviae MSPA (Mycoplasma synoviae surface protein A) proteincoded with a nucleic acid molecule of which the nucleotide sequence is as shown in SEQID NO:1 or a nucleic acid molecule of which the nucleotide sequence is 95% or above the same as that as shown in SEQID NO:1, and mycoplasma synoviae MSPB (Mycoplasma synoviae surface protein B) protein coded with a nucleic acid molecule of which the nucleotide sequence is as shown in SEQID NO:3 or a nucleic acidmolecule of which the nucleotide sequence is 95% or above the same as that as shown in SEQID NO:3. Sf9 cells of the vaccine are used for expressing MSPB protein and MSPA protein, the antigenicity, theimmunogenicity and the function of the product namely the immune composition are similar to those of natural protein, and the immune composition is high in expression level and high in immunogenicity, does not have pathogenicity to chickens; and besides, the vaccine can be prepared through large-scale serum-free suspension culture with a bioreactor, and besides, the production cost of the vaccinecan be greatly reduced.
Owner:苏州世诺生物技术有限公司
LAMP (loop-mediated isothermal amplification) visual detection kit for chicken mycoplasma synoviae (MS)
ActiveCN103131790AStrong specificityHigh detection sensitivityMicrobiological testing/measurementDNA/RNA fragmentationWater bathsMycoplasma synoviae
The invention discloses an LAMP (loop-mediated isothermal amplification) visual detection kit for chicken mycoplasma synoviae (MS). The invention provides an LAMP primer group for detecting the chicken mycoplasma synoviae. The LAMP primer group comprises a primer 1, a primer 2, a primer 3 and a primer 4, wherein the nucleotide sequences of the primer 1, the primer 2, the primer 3 and the primer 4 are respectively a sequence 1, a sequence 2, a sequence 3 and a sequence 4 in a sequence table. Experiments in the invention proof that the primer provided by the invention, the prepared MS-LAMP detection reagent and the created method have the characteristics of speediness, flexibility, specificity and simpleness, only one temperature controllable water bath kettle is used, and results can be determined by eyes instead of an instrument, so that the LAMP visual detection kit disclosed by the invention is applicable to rapid detection in a food products factory, a border port, a farm and a primary-level veterinary station, is significant in effective prevention and control of MS and has better application prospect.
Owner:GUANGXI VETERINARY RES INST
Mycoplasma synoviae indirect ELISA detection kit
PendingCN110221065AEfficient detectionQuick checkMaterial analysisAgainst vector-borne diseasesMycoplasma synoviaeMycoplasma
The present invention provides a Mycoplasma synoviae indirect ELISA detection kit. The kit uses main membrane antigen MSPB recombinant protein amplified by a strain of Mycoplasma synoviae Ningxia isolate through overlapping PCR as a coating antigen. The kit is capable of rapidly, specifically and efficiently detecting mycoplasma synoviae, to monitor prevalence of Mycoplasma synoviae in chicken flocks.
Owner:NINGXIA UNIVERSITY +1
RPA kit for rapidly detecting mycoplasma synoviae of chicken and its use
ActiveCN110305975AShorten the timeEasy to carryMicrobiological testing/measurementMicroorganism based processesMycoplasma synoviaeFluorescence
The invention discloses a RPA kit for rapidly detecting mycoplasma synoviae of chicken and its use. The kit comprises: a reaction tube containing RPA lyophilized particles, a reaction buffer solution,magnesium acetate, a pair of primers and a probe. The experiments prove that the sensitivity and specificity of the kit of the present invention are comparable to those of a qPCR method, and the entire reaction time is completed within 20 minutes, and the detection result only needs to be determined by the change of a fluorescence curve. Therefore, the kit of the invention has the advantages of quickness, high efficiency, sensitivity, and the like, provides a technical means for effectively detecting and identifying the mycoplasma synoviae of chicken, is easy and fast to operate, and is suitable for clinical veterinary on-site diagnosis and scientific research on mycoplasma synoviae of chicken.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
Mycoplasma synoviae culture medium and preparation method thereof
ActiveCN112410248AIncrease the titer of live bacteriaSimplify complex processesBacteriaMicroorganism based processesBiotechnologyAntigen
The invention relates to a mycoplasma synoviae culture medium and a preparation method thereof. The culture medium comprises a basal culture medium and auxiliary components. The basal culture medium comprises a phosphate buffer solution, glucose, lactoalbumin hydrolysate, coenzyme I, arginine hydrochloride, L-cysteine hydrochloride, MEM, yeast extract powder, 1% phenol red, and trehalose. The auxiliary components comprise pig serum and penicillin. According to the culture medium, the antigen content of mycoplasma synoviae bacterial liquid is remarkably increased, the bacterial liquid titer reaches up to 1012.0-13.0 CCU / ml. Meanwhile, the separation rate of the MS wild strains is remarkably improved and is as high as 93%. According to the preparation method of the culture medium, the antigen content of mycoplasma synoviae is increased, the production process is simplified, and the production cost is reduced.
Owner:山东滨州沃华生物工程有限公司
Preparation method and application of specific yolk antibody resisting mycoplasma synoviae diseases
InactiveCN111574625ANo side effectsEase of mass productionAntibacterial agentsEgg immunoglobulinsMycoplasma synoviaeDisease
The application discloses a preparation method of a specific yolk antibody resisting mycoplasma synoviae diseases. The preparation method comprises the following steps of recovering mycoplasma synoviae strains, performing propagation culture for three generations, performing sufficient inactivation, performing centrifuging, and taking precipitate so as to obtain a mycoplasma synoviae antigen; performing mixed emulsification on a mycoplasma synoviae antigen solution and a white oil adjuvant, performing basic immunization on each hen, and performing injection for 0.5ml; and after the basic immunization, performing strengthened immunization twice, wherein an immunization method and the dosage are the same as those of the basic immunization, after the first-time strengthened immunization, beginning to collect immunized eggs, disinfecting the obtained immunized eggs with alcohol, breaking shells, collecting yolk, and performing purifying to obtain the specific yolk antibody. The specific yolk antibody resisting mycoplasma synoviae diseases, prepared by the preparation method can effectively prevent and treat the mycoplasma synoviae diseases. The specific yolk antibody is easy in mass production and low in cost, and an obtained product is a safe preparation resisting the mycoplasma synoviae diseases.
Owner:NINGXIA UNIVERSITY +1
Double PCR primer set for simultaneous detection of MS-H vaccine strain and versatility and kit
ActiveCN110195120AStrong characteristicImprove accuracyMicrobiological testing/measurementMicroorganism based processesMycoplasma synoviaeMicrobiology
The invention belongs to the technical field of biological detection, and relates to a double PCR primer set for simultaneous detection of a MS-H vaccine strain and versatility and a kit. The primer set comprises two pairs of primers, which are an upstream and downstream primer pair of a MS-H vaccine strain and a universal upstream and downstream primer pair; wherein, the upstream and downstream primer pair of the MS-H vaccine strain include an upstream primer of the vaccine strain shown as SEQ ID NO: 1, and a downstream primer of the vaccine strain shown as SEQ ID NO: 2, and the universal upstream and downstream primer pair include the universal upstream primer shown as SEQ ID NO: 3 and the universal downstream primer shown as SEQ ID NO: 4. The kit provided by the invention is used to detect the chicken mycoplasma synoviae MS-H vaccine strain and the versatility, and has the advantages of high accuracy, high specificity, high sensitivity, easy operation, and rapid and reliable results.
Owner:青岛英赛特生物科技有限公司 +1
Fujian mycoplasma synoviae strain and culture medium thereof
ActiveCN113755368ATypical joint swelling symptomsPathogen characteristics are stableAntibacterial agentsBacterial antigen ingredientsBiotechnologyMycoplasma synoviae
The invention provides a mycoplasma synoviae strain and a culture medium thereof. The mycoplasma synoviae strain is separated from sick chicken attached joints with chicken mycoplasma synoviae in Fuzhou and belongs to typical strains in Fujian province. The strain is preserved in the China Center for Type Culture Collection, the preservation address is Wuhan University, Wuhan, China, the preservation number is CCTCC NO:M 2021210, and the preservation date is March 8, 2021. A culture medium for culturing the mycoplasma synoviae strain comprises the following components: brain heart leachate broth, yeast extract powder, inactivated fetal calf serum, an L-cysteine solution, an arginine solution, a phenol red solution and a coenzyme I solution, and the pH value of the culture medium is 7.6-7.8. The mycoplasma synoviae strain is inoculated to the culture medium and placed in an incubator at the temperature of 37 DEG C to be subjected to static culture for 36 h, the growth peak value of the mycoplasma synoviae strain can be reached, and the viable count of the cultured mycoplasma synoviae is not lower than 10<12> CCU / ml.
Owner:FUJIAN AGRI & FORESTRY UNIV
Salmonella pullorum and mycoplasma synoviae double-plate agglutination antigen as well as preparation method and application thereof
ActiveCN113265358AIncreased sensitivityStrong specificityBacteriaMicroorganism based processesBiotechnologyMycoplasma synoviae
Owner:SHANDONG BINZHOU ANIMAL SCI & VETERINARY MEDICINE ACADEMY
Chicken mycoplasma synoviae inactivated vaccine
ActiveCN113957007AReduce morbidityEpidemic preventionAntibacterial agentsBacterial antigen ingredientsMycoplasma synoviaeTGE VACCINE
The invention discloses a chicken mycoplasma synoviae inactivated vaccine which comprises an antigen and a vaccine adjuvant, and the antigen is an inactivated mycoplasma synoviae MS-FJ01 strain; the strain is separated from sick chicken attached joints with chicken mycoplasma synoviae in Fuzhou, and belongs to a typical strain in Fujian province; the strain is preserved in the China Center for Type Culture Collection, the preservation address is Wuhan, China, the preservation number is CCTCC NO: M 2021210, and the preservation date is March 8, 2021; according to the scheme, the vaccine can generate a high-level antibody, the immunization duration is long, the morbidity of the immunized chicken mycoplasma synoviae is obviously reduced, and the prevalence of the chicken mycoplasma synoviae can be effectively prevented; the chicken mycoplasma synoviae inactivated vaccine prepared from the mycoplasma synoviae MS-FJ01 strain in the scheme can effectively prevent and control the chicken mycoplasma synoviae, the richness of commercially available vaccines of the category is improved, and an optional scheme is provided.
Owner:FUJIAN AGRI & FORESTRY UNIV
Composition for preventing or treating mycoplasma synoviae infection
ActiveUS20210322530A1EffectAvoid infectionAntibacterial agentsBacterial antigen ingredientsMycoplasma synoviaePoultry disease
The present disclosure relates to a composition for preventing and treating Mycoplasma synoviae infection, the composition comprising Tuf, NOX, MS53-0285 or a combination thereof as active ingredients. The composition of the present disclosure is effective in alleviating symptoms caused by Mycoplasma synoviae infection and can be used as an effective tool in preventing or treating poultry diseases.
Owner:AGRI TECH RES INST
Preparation method of mycoplasma synoviae monoclonal antibody
PendingCN111748034AImprove specific recognitionEasy to identifyImmunoglobulins against bacteriaMicroorganism based processesBALB/cMycoplasma synoviae
The invention discloses a preparation method of a mycoplasma synoviae monoclonal antibody. The conservative analysis is carried out on two imaginary membrane proteins with the mycoplasma membrane surface protein sizes of 20Kda and 13Kda; then recombinant plasmids synthesizing, protein inducible expression, and affinity chromatography purification are carried out; the purified recombinant protein is used as immunogen to immunize BALB / c mice, cell fusion is carried out after antibody detection is qualified, a single monoclonal antibody cell strain is obtained after subcloning of fusion cells, and the prepared monoclonal antibody can well and specifically recognize mycoplasma synoviae antigen.
Owner:中元牧康(武汉)检测技术服务有限公司
Mycoplasma synoviae antigen protein LP85, ELISA detection method of corresponding antibody and kit
ActiveCN112538106AStrong specificityIncreased sensitivityDepsipeptidesNucleic acid vectorMycoplasma synoviaeElisa kit
The invention provides a mycoplasma synoviae antigen protein LP85, an established ELISA method for detecting a corresponding antibody of mycoplasma synoviae, an ELISA kit prepared according to the method and a corresponding using method. Based on the mycoplasma synoviae antigen protein LP85, especially a mycoplasma synoviae recombinant expression protein LP85, the ELISA detection method of the corresponding antibody and the ELISA kit prepared according to the method have the characteristics of better specificity and sensitivity and good detection repeatability compared with an existing detection form.
Owner:SHANGHAI VETERINARY RES INST CHINESE ACAD OF AGRI SCI
Mycoplasma synoviae virulent strain and application thereof
ActiveCN112779193AHigh pathogenicityImproving immunogenicityAntibacterial agentsBacterial antigen ingredientsMycoplasma synoviaeOil adjuvant
The invention provides a mycoplasma synoviae virulent strain and application thereof. A chicken flock infected by a certain synovial sac in Fujian Province is subjected to MS separation, purification and identification and then named as an MS FZ strain, SPF chickens infected by a pure culture of the MS FZ strain and aged 10-11 weeks have high pathogenicity, and at least 80% of the SPF chickens have air sacculitis; and the MS FZ strain is inactivated through formaldehyde and then emulsified with an oil adjuvant to prepare an inactivated vaccine, the inactivated vaccine is used for immunizing the SPF chickens twice, then a fresh culture of the MS FZ strain is used for counteracting toxic substances to verify the vaccine protection force, and the result shows that at least 80% of the SPF chickens obtain immune protection. Therefore, the separated MS FZ virulent strain can be used as a virulent strain for inspection of effectiveness evaluation of different drugs or prevention and treatment methods and can be used as a vaccine candidate strain for preparing an MS inactivated vaccine.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY FUJIAN ACADEMY OF AGRI SCI
PCR detection kit for rapidly identifying mycoplasma hyopeumoniae, mycoplasma synoviae and mycoplasma hyorhinis, and applications of PCR detection kit
InactiveCN106319080AAvoid pollutionLow detection limitMicrobiological testing/measurementMycoplasma synoviaePositive control
The invention belongs to the technical field of PCR, and particularly relates to a PCR detection kit for rapidly identifying mycoplasma hyopeumoniae, mycoplasma synoviae and mycoplasma hyorhinis, and applications of the PCR detection kit. The PCR detection kit comprises PCR premix buffering solution, superpure water, Marker DL2000, upstream primer, downstream primer, a negative control and a positive control. The sequence of the upstream primer is 5'-ACACCATGGGAGCTGGTAAT-3'; the sequence of the downstream primer is 5'-GTTCATCGACTTTCAGACCCAAGGCAT-3'. The PCR kit has the advantages of being low in detection limit, good in sensitivity, strong in specificity and the like, can rapidly detect and identify mycoplasma hyopeumoniae, mycoplasma synoviae and mycoplasma hyorhinis.
Owner:WUHAN KEQIAN BIOLOGY CO LTD
Mycoplasma synoviae culture medium and preparation method thereof
PendingCN113957012AEasy to prepareSmall batch-to-batch varianceBacteriaMicroorganism based processesBiotechnologyHeterologous
The invention relates to a mycoplasma synoviae culture medium and a preparation method thereof, and belongs to the technical field of veterinary biology. The mycoplasma synoviae culture medium is composed of a basic culture medium and an auxiliary culture medium, the basic culture medium mainly comprises Hank's concentrated solution, milk protein hydrolysate, yeast extract, beef heart extract powder and trehalose, and a high-pressure steam sterilization mode is used for sterilization; the auxiliary culture medium is prepared from arginine, sodium pyruvate, coenzyme I, penicillin and porcine serum, and all the components of the auxiliary culture medium are filtered and sterilized. The titer of the mycoplasma synoviae cultured by the culture medium disclosed by the invention reaches 1010-1011CCU / ml, the culture time is 14-24h, the content of porcine serum is as low as 5%, and the stress reaction of heterologous to chickens and the production cost of enterprises are greatly reduced. The inactivated vaccine prepared from the mycoplasma synoviae cultured by the culture medium has good safety and immunogenicity.
Owner:JIANGSU NANNONG HI TECH
Coating antigen for detecting mycoplasma synoviae antibody, kit and detection method thereof
PendingCN114324859AEfficient detectionInfection controlMaterial analysisMycoplasma synoviaeNucleotide
The invention relates to the technical field of biology, in particular to a coating antigen for detecting a mycoplasma synoviae antibody, a kit and a detection method thereof. Detecting that a coating antigen of the mycoplasma synoviae antibody is a recombinant EFG protein; the amino acid sequence of the recombinant EFG protein comprises a sequence as shown in SEQ ID NO: 1; the nucleotide sequence of the recombinant EFG protein comprises a sequence as shown in SEQ ID NO: 2. The recombinant EFG protein is used as the coating antigen of the ELISA method for detecting the mycoplasma synoviae antibody, can be used for clinical detection of the mycoplasma synoviae serum antibody, and efficiently detects the mycoplasma synoviae antibody in a farm; according to the present invention, the recombinant EFG protein is adopted as the coating antigen of the ELISA method for detecting the mycoplasma synoviae antibody, such that the detection method has good reactogenicity, specificity, sensitivity and repeatability, can be used for clinical mycoplasma synoviae serum antibody detection, provides certain guidance for the formulation of the mycoplasma synoviae vaccine immune program, and provides the important significance for the clinical detection of the mycoplasma synoviae serum antibody. Therefore, the aim of preventing and controlling mycoplasma synoviae infection is achieved.
Owner:WENS FOODSTUFF GRP CO LTD +1
Plant extract composition for inhibiting mycoplasma synoviae, and preparation method and use method of plant extract composition
ActiveCN113171416APlay an inhibitory roleReduce morbidityAntibacterial agentsPharmaceutical delivery mechanismBiotechnologyMycoplasma synoviae
The invention relates to the field of animal medicines, and particularly discloses a plant extract composition for inhibiting mycoplasma synoviae, and a preparation method and a use method of the plant extract composition. The plant extract composition for inhibiting the mycoplasma synoviae of the chicken comprises plant extracts, and the plant extracts comprise one or a combination of multiple of a dry aloe extract, a semen raphani extract, a folium cortex eucommiae extract, a radix scutellariae extract, a fructus forsythiae extract, a Chinese pulsatilla root extract, a rhizoma ligustici extract and a cortex acanthopanacis extract. The plant extract composition for inhibiting the mycoplasma synoviae has the advantage of effectively inhibiting the mycoplasma synoviae, so that the mycoplasma synoviae is prevented and controlled, and the morbidity of the mycoplasma synoviae is reduced. Meanwhile, the plant extract composition for inhibiting the mycoplasma synoviae is not easy to generate drug resistance, and has the advantages of being natural, free of toxic and side effects, free of drug resistance and free of residues.
Owner:BIOFORTE BIOTECHSHENZHEN CO LTD
Enrofloxacin nano-microemulsion solution for treating Mycoplasma synoviae disease in poultry
InactiveCN111053739AGood treatment effectImprove solubilityAntibacterial agentsOrganic active ingredientsBiotechnologyMycoplasma synoviae
The invention discloses an enrofloxacin nano-microemulsion solution for treating Mycoplasma synoviae disease in poultry. The nano-microemulsion is prepared by the following method: preparing raw materials including 5-15 parts by weight of enrofloxacin, 5-15 parts by weight of an oil phase, 5-20 parts by weight of a surfactant, 5-20 parts by weight of a cosurfactant, and 30-80 parts by weight of awater phase; adding enrofloxacin, the surfactant and the cosurfactant into a reaction device, and dispersing in a water phase through stirring, ultrasonic treatment or homogenization treatment to obtain an emulsion; slowly adding the emulsion into an oil phase, introducing nitrogen to expel oxygen, and adding a mixture of initiators; and carrying out external cooling and polymerization on the above reaction to obtain the enrofloxacin nano-microemulsion solution. The invention aims to provide an enrofloxacin nano-microemulsion solution for treating Mycoplasma synoviae disease in poultry. The process effect of adopting a nano-microemulsion preparation is more stable than the effect of a common oral solution, and the enrofloxacin nano-microemulsion solution shows a better therapeutic effect on Mycoplasma synoviae disease in poultry.
Owner:天津佰力喜动物药业有限公司
Avian mycoplasma culture medium, preparation method of avian mycoplasma solution and applications of avian mycoplasma culture medium and avian mycoplasma solution
ActiveCN109385385AHigh antigen contentReduce the chance of immune side effectsAntibacterial agentsBacterial antigen ingredientsAntigenMycoplasma synoviae
The invention relates to an avian mycoplasma culture medium, a preparation method of an avian mycoplasma solution and applications of the avian mycoplasma culture medium and the avian mycoplasma solution, and belongs to the technical field of biology. The avian mycoplasma culture medium comprises a basal culture medium and auxiliary components, wherein the basal culture medium is a conventional avian mycoplasma liquid culture medium, and the auxiliary components comprise gelatin, Tween 80 and calcium chloride; a strain for production is mycoplasma galliscepticum or mycoplasma synoviae, the avian mycoplasma solution is produced by solution inoculation, culture and harvesting, and an avian mycoplasma vaccine is prepared. According to the preparation method, antigen content of the avian mycoplasma solution is increased, production technology is simplified, production cost is reduced, probability of occurrence of vaccine immunity side effects is reduced, and vaccine immunity effect is improved.
Owner:RINGPU (BAODING) BIOLOGICAL PHARMACEUTICAL CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com